Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)
China flag China · Delayed Price · Currency is CNY
6.84
+0.08 (1.18%)
At close: Feb 4, 2026

SHE:002412 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
127.88128.0251.13145.4190.31103.56
Trading Asset Securities
357.16244.12203.87135.8249.24-
Cash & Short-Term Investments
485.03372.14255281.23139.55103.56
Cash Growth
30.80%45.94%-9.33%101.52%34.75%-24.19%
Accounts Receivable
446.03425.03352.52320.57272.88277.62
Other Receivables
16.380.880.6311.961.8635.15
Receivables
462.42442359.99332.53274.74312.77
Inventory
208.15222.88231.12246.62103.3784.43
Prepaid Expenses
-6.93.8-1.232.71
Other Current Assets
89.8979.2546.165.0316.5123.99
Total Current Assets
1,2451,123896.07865.4535.41527.46
Property, Plant & Equipment
463.87489.16515.61439.45470.75485.63
Long-Term Investments
771.82855.75841.81781.35707.95628.39
Goodwill
14.7914.7914.7914.7953.0392.66
Other Intangible Assets
28.9429.329.5433.7242.5852.1
Long-Term Deferred Tax Assets
2.222.422.52.042.112.36
Long-Term Deferred Charges
15.1514.4115.1315.7116.4217.14
Other Long-Term Assets
20.2118.2321.04138.47283.0382.92
Total Assets
2,5622,5472,3362,2912,1111,889
Accounts Payable
25.9941.6241.1143.6351.4438.12
Accrued Expenses
17.7948.3162.5866.8348.3130.54
Short-Term Debt
55.0584.5195.12120.15131.79178
Current Income Taxes Payable
6.776.2311.644.614.520.34
Current Unearned Revenue
0.972.726.487.021.713.52
Other Current Liabilities
170.76134.93138.51138113.3322.91
Total Current Liabilities
277.34318.32355.42380.24351.11273.43
Long-Term Unearned Revenue
23.4624.5416.8115.0316.2218.12
Long-Term Deferred Tax Liabilities
0.8711.221.541.662.37
Total Liabilities
301.66343.85373.46396.81368.99293.92
Common Stock
503.2503.2503.2503.2503.2503.2
Additional Paid-In Capital
234.12234.12234.12234.12232.77202.31
Retained Earnings
1,5181,4361,2151,161993.7897.86
Comprehensive Income & Other
5.3730.4510.34-4.512.63-8.65
Total Common Equity
2,2612,2031,9631,8941,7421,595
Shareholders' Equity
2,2612,2031,9631,8941,7421,595
Total Liabilities & Equity
2,5622,5472,3362,2912,1111,889
Total Debt
55.0584.5195.12120.15131.79178
Net Cash (Debt)
429.98287.63159.88161.087.76-74.44
Net Cash Growth
47.75%79.90%-0.74%1975.89%--
Net Cash Per Share
0.850.570.320.320.02-0.15
Filing Date Shares Outstanding
503.2503.2503.2503.2503.2503.2
Total Common Shares Outstanding
503.2503.2503.2503.2503.2503.2
Working Capital
968.15804.85540.65485.17184.3254.03
Book Value Per Share
4.494.383.903.763.463.17
Tangible Book Value
2,2172,1591,9191,8461,6471,450
Tangible Book Value Per Share
4.414.293.813.673.272.88
Buildings
-647.47644.48531.89533.67499.4
Machinery
-228.7223.66221.69218.69207.09
Construction In Progress
-10.89.086.095.2626.72
Source: S&P Global Market Intelligence. Standard template. Financial Sources.